Read about the latest industry insights
Why pharma should spend an hour or two on Total Landed Cost
When shipping vaccines or any other temperature-sensitive medical solution, pharmaceutical companies look for partners that ensure high quality, that can simplify the handling process, and help to reduce CO2 emissions. While active temperature-controlled solutions meet all those requirements, the general perception is that they are more expensive. That perception sometimes makes pharmaceutical companies choose other, seemingly less costly alternatives, commonly known as passive solutions, not realizing that they are in essence, paying more for an inferior solution.
Different alternatives for temperature-controlled transport
Breakthrough research in various medical fields, such as gene editing, stem cell technology and regenerative medicine, has led to an increased demand for temperature-controlled transport. High-end, specialized medicine is often produced in low volumes with no backup stock and thus, delivering these sensitive products safely across the globe has become a mounting logistical challenge. Selecting a secure and reliable logistics solution has accordingly become all the more important.
Reinventing the procurement process of pharma logistics
With the growing number of sensitive drugs, how can procurement keep transport costs under control while still adhering to necessary quality requirements?
Are you familiar with the cold chain linguistics? Numerous abbreviations and internal phrases are used every day in the cold chain industry. To increase your knowledge of the industry, we will guide you through the terminology.